nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—CYP2A6—Methoxsalen—psoriasis	0.131	0.186	CbGbCtD
Azithromycin—CYP1A2—Clobetasol propionate—psoriasis	0.0953	0.135	CbGbCtD
Azithromycin—CYP2A6—Prednisolone—psoriasis	0.0638	0.0906	CbGbCtD
Azithromycin—CYP1A2—Methoxsalen—psoriasis	0.0501	0.0711	CbGbCtD
Azithromycin—CYP2A6—Dexamethasone—psoriasis	0.0376	0.0534	CbGbCtD
Azithromycin—CYP3A4—Calcitriol—psoriasis	0.0337	0.0479	CbGbCtD
Azithromycin—CYP3A4—Methoxsalen—psoriasis	0.0262	0.0372	CbGbCtD
Azithromycin—ABCB1—Mycophenolate mofetil—psoriasis	0.0252	0.0357	CbGbCtD
Azithromycin—ABCB1—Betamethasone—psoriasis	0.0216	0.0306	CbGbCtD
Azithromycin—ABCB1—Prednisolone—psoriasis	0.0213	0.0302	CbGbCtD
Azithromycin—ABCB1—Hydrocortisone—psoriasis	0.0202	0.0286	CbGbCtD
Azithromycin—ABCB1—Prednisone—psoriasis	0.0201	0.0285	CbGbCtD
Azithromycin—ABCB1—Cyclosporine—psoriasis	0.0191	0.0271	CbGbCtD
Azithromycin—CYP3A4—Cholecalciferol—psoriasis	0.0174	0.0247	CbGbCtD
Azithromycin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0151	0.0214	CbGbCtD
Azithromycin—CYP3A4—Triamcinolone—psoriasis	0.0151	0.0214	CbGbCtD
Azithromycin—CYP3A4—Betamethasone—psoriasis	0.0129	0.0184	CbGbCtD
Azithromycin—CYP3A4—Prednisolone—psoriasis	0.0128	0.0181	CbGbCtD
Azithromycin—ABCB1—Dexamethasone—psoriasis	0.0126	0.0178	CbGbCtD
Azithromycin—CYP3A4—Hydrocortisone—psoriasis	0.0121	0.0172	CbGbCtD
Azithromycin—CYP3A4—Prednisone—psoriasis	0.012	0.0171	CbGbCtD
Azithromycin—CYP3A4—Cyclosporine—psoriasis	0.0114	0.0162	CbGbCtD
Azithromycin—ABCB1—Methotrexate—psoriasis	0.0101	0.0143	CbGbCtD
Azithromycin—CYP3A4—Dexamethasone—psoriasis	0.00752	0.0107	CbGbCtD
Azithromycin—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.000439	0.153	CbGpPWpGaD
Azithromycin—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.000272	0.0949	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL22—psoriasis	0.00013	0.0453	CbGpPWpGaD
Azithromycin—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000129	0.0451	CbGpPWpGaD
Azithromycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000113	0.0394	CbGpPWpGaD
Azithromycin—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000112	0.0389	CbGpPWpGaD
Azithromycin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	9.98e-05	0.0348	CbGpPWpGaD
Azithromycin—Loss of consciousness—Betamethasone—psoriasis	9.66e-05	0.00033	CcSEcCtD
Azithromycin—Dizziness—Mycophenolic acid—psoriasis	9.65e-05	0.00033	CcSEcCtD
Azithromycin—Paraesthesia—Prednisolone—psoriasis	9.65e-05	0.00033	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.56e-05	0.000327	CcSEcCtD
Azithromycin—Hyperhidrosis—Triamcinolone—psoriasis	9.56e-05	0.000327	CcSEcCtD
Azithromycin—Convulsion—Dexamethasone—psoriasis	9.52e-05	0.000325	CcSEcCtD
Azithromycin—Convulsion—Betamethasone—psoriasis	9.52e-05	0.000325	CcSEcCtD
Azithromycin—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.5e-05	0.000325	CcSEcCtD
Azithromycin—Insomnia—Hydrocortisone—psoriasis	9.49e-05	0.000325	CcSEcCtD
Azithromycin—Hypertension—Betamethasone—psoriasis	9.49e-05	0.000324	CcSEcCtD
Azithromycin—Hypertension—Dexamethasone—psoriasis	9.49e-05	0.000324	CcSEcCtD
Azithromycin—Paraesthesia—Hydrocortisone—psoriasis	9.43e-05	0.000322	CcSEcCtD
Azithromycin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.42e-05	0.000322	CcSEcCtD
Azithromycin—Urticaria—Cyclosporine—psoriasis	9.38e-05	0.000321	CcSEcCtD
Azithromycin—Myalgia—Betamethasone—psoriasis	9.36e-05	0.00032	CcSEcCtD
Azithromycin—Myalgia—Dexamethasone—psoriasis	9.36e-05	0.00032	CcSEcCtD
Azithromycin—Body temperature increased—Cyclosporine—psoriasis	9.34e-05	0.000319	CcSEcCtD
Azithromycin—Abdominal pain—Cyclosporine—psoriasis	9.34e-05	0.000319	CcSEcCtD
Azithromycin—Anxiety—Dexamethasone—psoriasis	9.32e-05	0.000319	CcSEcCtD
Azithromycin—Anxiety—Betamethasone—psoriasis	9.32e-05	0.000319	CcSEcCtD
Azithromycin—Vomiting—Mycophenolic acid—psoriasis	9.28e-05	0.000317	CcSEcCtD
Azithromycin—Discomfort—Dexamethasone—psoriasis	9.24e-05	0.000316	CcSEcCtD
Azithromycin—Discomfort—Betamethasone—psoriasis	9.24e-05	0.000316	CcSEcCtD
Azithromycin—Dyspepsia—Hydrocortisone—psoriasis	9.24e-05	0.000316	CcSEcCtD
Azithromycin—Rash—Mycophenolic acid—psoriasis	9.21e-05	0.000315	CcSEcCtD
Azithromycin—Dermatitis—Mycophenolic acid—psoriasis	9.2e-05	0.000314	CcSEcCtD
Azithromycin—Pain—Prednisolone—psoriasis	9.19e-05	0.000314	CcSEcCtD
Azithromycin—Hepatitis—Methotrexate—psoriasis	9.19e-05	0.000314	CcSEcCtD
Azithromycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.17e-05	0.032	CbGpPWpGaD
Azithromycin—Urticaria—Mycophenolate mofetil—psoriasis	9.15e-05	0.000313	CcSEcCtD
Azithromycin—Headache—Mycophenolic acid—psoriasis	9.15e-05	0.000313	CcSEcCtD
Azithromycin—Decreased appetite—Hydrocortisone—psoriasis	9.13e-05	0.000312	CcSEcCtD
Azithromycin—Body temperature increased—Mycophenolate mofetil—psoriasis	9.11e-05	0.000311	CcSEcCtD
Azithromycin—Abdominal pain—Mycophenolate mofetil—psoriasis	9.11e-05	0.000311	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.06e-05	0.00031	CcSEcCtD
Azithromycin—Fatigue—Hydrocortisone—psoriasis	9.05e-05	0.000309	CcSEcCtD
Azithromycin—Vision blurred—Prednisone—psoriasis	9.02e-05	0.000308	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.01e-05	0.000308	CcSEcCtD
Azithromycin—Pain—Hydrocortisone—psoriasis	8.98e-05	0.000307	CcSEcCtD
Azithromycin—Oedema—Betamethasone—psoriasis	8.97e-05	0.000307	CcSEcCtD
Azithromycin—Oedema—Dexamethasone—psoriasis	8.97e-05	0.000307	CcSEcCtD
Azithromycin—Anaphylactic shock—Dexamethasone—psoriasis	8.97e-05	0.000307	CcSEcCtD
Azithromycin—Anaphylactic shock—Betamethasone—psoriasis	8.97e-05	0.000307	CcSEcCtD
Azithromycin—Insomnia—Triamcinolone—psoriasis	8.94e-05	0.000306	CcSEcCtD
Azithromycin—Infection—Betamethasone—psoriasis	8.91e-05	0.000305	CcSEcCtD
Azithromycin—Infection—Dexamethasone—psoriasis	8.91e-05	0.000305	CcSEcCtD
Azithromycin—Ill-defined disorder—Prednisone—psoriasis	8.88e-05	0.000304	CcSEcCtD
Azithromycin—Paraesthesia—Triamcinolone—psoriasis	8.88e-05	0.000303	CcSEcCtD
Azithromycin—Feeling abnormal—Prednisolone—psoriasis	8.86e-05	0.000303	CcSEcCtD
Azithromycin—Visual impairment—Methotrexate—psoriasis	8.85e-05	0.000303	CcSEcCtD
Azithromycin—Anaemia—Prednisone—psoriasis	8.85e-05	0.000302	CcSEcCtD
Azithromycin—Shock—Betamethasone—psoriasis	8.82e-05	0.000302	CcSEcCtD
Azithromycin—Shock—Dexamethasone—psoriasis	8.82e-05	0.000302	CcSEcCtD
Azithromycin—Dyspnoea—Triamcinolone—psoriasis	8.81e-05	0.000301	CcSEcCtD
Azithromycin—Agitation—Prednisone—psoriasis	8.79e-05	0.000301	CcSEcCtD
Azithromycin—Thrombocytopenia—Dexamethasone—psoriasis	8.78e-05	0.0003	CcSEcCtD
Azithromycin—Thrombocytopenia—Betamethasone—psoriasis	8.78e-05	0.0003	CcSEcCtD
Azithromycin—Angioedema—Prednisone—psoriasis	8.74e-05	0.000299	CcSEcCtD
Azithromycin—Hypersensitivity—Cyclosporine—psoriasis	8.7e-05	0.000297	CcSEcCtD
Azithromycin—Dyspepsia—Triamcinolone—psoriasis	8.7e-05	0.000297	CcSEcCtD
Azithromycin—Erythema multiforme—Methotrexate—psoriasis	8.69e-05	0.000297	CcSEcCtD
Azithromycin—Nausea—Mycophenolic acid—psoriasis	8.67e-05	0.000296	CcSEcCtD
Azithromycin—Hyperhidrosis—Betamethasone—psoriasis	8.67e-05	0.000296	CcSEcCtD
Azithromycin—Hyperhidrosis—Dexamethasone—psoriasis	8.67e-05	0.000296	CcSEcCtD
Azithromycin—Feeling abnormal—Hydrocortisone—psoriasis	8.65e-05	0.000296	CcSEcCtD
Azithromycin—Malaise—Prednisone—psoriasis	8.63e-05	0.000295	CcSEcCtD
Azithromycin—Vertigo—Prednisone—psoriasis	8.6e-05	0.000294	CcSEcCtD
Azithromycin—Gastrointestinal pain—Hydrocortisone—psoriasis	8.58e-05	0.000293	CcSEcCtD
Azithromycin—Syncope—Prednisone—psoriasis	8.58e-05	0.000293	CcSEcCtD
Azithromycin—Tinnitus—Methotrexate—psoriasis	8.57e-05	0.000293	CcSEcCtD
Azithromycin—Anorexia—Betamethasone—psoriasis	8.55e-05	0.000292	CcSEcCtD
Azithromycin—Anorexia—Dexamethasone—psoriasis	8.55e-05	0.000292	CcSEcCtD
Azithromycin—Urticaria—Prednisolone—psoriasis	8.54e-05	0.000292	CcSEcCtD
Azithromycin—Fatigue—Triamcinolone—psoriasis	8.52e-05	0.000291	CcSEcCtD
Azithromycin—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.49e-05	0.00029	CcSEcCtD
Azithromycin—Asthenia—Cyclosporine—psoriasis	8.47e-05	0.00029	CcSEcCtD
Azithromycin—Pain—Triamcinolone—psoriasis	8.45e-05	0.000289	CcSEcCtD
Azithromycin—Loss of consciousness—Prednisone—psoriasis	8.41e-05	0.000288	CcSEcCtD
Azithromycin—Hypotension—Dexamethasone—psoriasis	8.38e-05	0.000286	CcSEcCtD
Azithromycin—Hypotension—Betamethasone—psoriasis	8.38e-05	0.000286	CcSEcCtD
Azithromycin—Pruritus—Cyclosporine—psoriasis	8.36e-05	0.000286	CcSEcCtD
Azithromycin—Urticaria—Hydrocortisone—psoriasis	8.34e-05	0.000285	CcSEcCtD
Azithromycin—Abdominal pain—Hydrocortisone—psoriasis	8.3e-05	0.000284	CcSEcCtD
Azithromycin—Body temperature increased—Hydrocortisone—psoriasis	8.3e-05	0.000284	CcSEcCtD
Azithromycin—Convulsion—Prednisone—psoriasis	8.29e-05	0.000283	CcSEcCtD
Azithromycin—Asthenia—Mycophenolate mofetil—psoriasis	8.27e-05	0.000283	CcSEcCtD
Azithromycin—Hypertension—Prednisone—psoriasis	8.26e-05	0.000282	CcSEcCtD
Azithromycin—Chills—Methotrexate—psoriasis	8.24e-05	0.000282	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Betamethasone—psoriasis	8.17e-05	0.000279	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.17e-05	0.000279	CcSEcCtD
Azithromycin—Pruritus—Mycophenolate mofetil—psoriasis	8.15e-05	0.000279	CcSEcCtD
Azithromycin—Myalgia—Prednisone—psoriasis	8.15e-05	0.000279	CcSEcCtD
Azithromycin—Arthralgia—Prednisone—psoriasis	8.15e-05	0.000279	CcSEcCtD
Azithromycin—Feeling abnormal—Triamcinolone—psoriasis	8.15e-05	0.000278	CcSEcCtD
Azithromycin—Anxiety—Prednisone—psoriasis	8.12e-05	0.000278	CcSEcCtD
Azithromycin—Insomnia—Dexamethasone—psoriasis	8.11e-05	0.000277	CcSEcCtD
Azithromycin—Insomnia—Betamethasone—psoriasis	8.11e-05	0.000277	CcSEcCtD
Azithromycin—Diarrhoea—Cyclosporine—psoriasis	8.08e-05	0.000276	CcSEcCtD
Azithromycin—Paraesthesia—Betamethasone—psoriasis	8.05e-05	0.000275	CcSEcCtD
Azithromycin—Paraesthesia—Dexamethasone—psoriasis	8.05e-05	0.000275	CcSEcCtD
Azithromycin—Discomfort—Prednisone—psoriasis	8.05e-05	0.000275	CcSEcCtD
Azithromycin—Hypersensitivity—Prednisolone—psoriasis	7.92e-05	0.000271	CcSEcCtD
Azithromycin—Dyspepsia—Betamethasone—psoriasis	7.89e-05	0.00027	CcSEcCtD
Azithromycin—Dyspepsia—Dexamethasone—psoriasis	7.89e-05	0.00027	CcSEcCtD
Azithromycin—Diarrhoea—Mycophenolate mofetil—psoriasis	7.88e-05	0.000269	CcSEcCtD
Azithromycin—Urticaria—Triamcinolone—psoriasis	7.85e-05	0.000268	CcSEcCtD
Azithromycin—Dysgeusia—Methotrexate—psoriasis	7.83e-05	0.000268	CcSEcCtD
Azithromycin—Body temperature increased—Triamcinolone—psoriasis	7.81e-05	0.000267	CcSEcCtD
Azithromycin—Dizziness—Cyclosporine—psoriasis	7.81e-05	0.000267	CcSEcCtD
Azithromycin—Anaphylactic shock—Prednisone—psoriasis	7.81e-05	0.000267	CcSEcCtD
Azithromycin—Oedema—Prednisone—psoriasis	7.81e-05	0.000267	CcSEcCtD
Azithromycin—Decreased appetite—Dexamethasone—psoriasis	7.8e-05	0.000267	CcSEcCtD
Azithromycin—Decreased appetite—Betamethasone—psoriasis	7.8e-05	0.000267	CcSEcCtD
Azithromycin—Infection—Prednisone—psoriasis	7.76e-05	0.000265	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Dexamethasone—psoriasis	7.74e-05	0.000265	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Betamethasone—psoriasis	7.74e-05	0.000265	CcSEcCtD
Azithromycin—Hypersensitivity—Hydrocortisone—psoriasis	7.73e-05	0.000264	CcSEcCtD
Azithromycin—Fatigue—Dexamethasone—psoriasis	7.73e-05	0.000264	CcSEcCtD
Azithromycin—Fatigue—Betamethasone—psoriasis	7.73e-05	0.000264	CcSEcCtD
Azithromycin—Shock—Prednisone—psoriasis	7.68e-05	0.000263	CcSEcCtD
Azithromycin—Pain—Betamethasone—psoriasis	7.67e-05	0.000262	CcSEcCtD
Azithromycin—Pain—Dexamethasone—psoriasis	7.67e-05	0.000262	CcSEcCtD
Azithromycin—Dizziness—Mycophenolate mofetil—psoriasis	7.62e-05	0.00026	CcSEcCtD
Azithromycin—Hyperhidrosis—Prednisone—psoriasis	7.55e-05	0.000258	CcSEcCtD
Azithromycin—Vision blurred—Methotrexate—psoriasis	7.54e-05	0.000258	CcSEcCtD
Azithromycin—Asthenia—Hydrocortisone—psoriasis	7.53e-05	0.000257	CcSEcCtD
Azithromycin—Vomiting—Cyclosporine—psoriasis	7.51e-05	0.000257	CcSEcCtD
Azithromycin—Rash—Cyclosporine—psoriasis	7.45e-05	0.000255	CcSEcCtD
Azithromycin—Anorexia—Prednisone—psoriasis	7.45e-05	0.000254	CcSEcCtD
Azithromycin—Dermatitis—Cyclosporine—psoriasis	7.44e-05	0.000254	CcSEcCtD
Azithromycin—Pruritus—Hydrocortisone—psoriasis	7.43e-05	0.000254	CcSEcCtD
Azithromycin—Ill-defined disorder—Methotrexate—psoriasis	7.42e-05	0.000254	CcSEcCtD
Azithromycin—Headache—Cyclosporine—psoriasis	7.4e-05	0.000253	CcSEcCtD
Azithromycin—Anaemia—Methotrexate—psoriasis	7.39e-05	0.000253	CcSEcCtD
Azithromycin—Feeling abnormal—Betamethasone—psoriasis	7.39e-05	0.000253	CcSEcCtD
Azithromycin—Feeling abnormal—Dexamethasone—psoriasis	7.39e-05	0.000253	CcSEcCtD
Azithromycin—Gastrointestinal pain—Dexamethasone—psoriasis	7.33e-05	0.000251	CcSEcCtD
Azithromycin—Gastrointestinal pain—Betamethasone—psoriasis	7.33e-05	0.000251	CcSEcCtD
Azithromycin—Vomiting—Mycophenolate mofetil—psoriasis	7.33e-05	0.00025	CcSEcCtD
Azithromycin—Hypersensitivity—Triamcinolone—psoriasis	7.28e-05	0.000249	CcSEcCtD
Azithromycin—Rash—Mycophenolate mofetil—psoriasis	7.27e-05	0.000248	CcSEcCtD
Azithromycin—Dermatitis—Mycophenolate mofetil—psoriasis	7.26e-05	0.000248	CcSEcCtD
Azithromycin—Headache—Mycophenolate mofetil—psoriasis	7.22e-05	0.000247	CcSEcCtD
Azithromycin—Malaise—Methotrexate—psoriasis	7.21e-05	0.000247	CcSEcCtD
Azithromycin—Vertigo—Methotrexate—psoriasis	7.19e-05	0.000246	CcSEcCtD
Azithromycin—Diarrhoea—Hydrocortisone—psoriasis	7.18e-05	0.000246	CcSEcCtD
Azithromycin—Leukopenia—Methotrexate—psoriasis	7.16e-05	0.000245	CcSEcCtD
Azithromycin—Urticaria—Dexamethasone—psoriasis	7.12e-05	0.000244	CcSEcCtD
Azithromycin—Urticaria—Betamethasone—psoriasis	7.12e-05	0.000244	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Prednisone—psoriasis	7.12e-05	0.000243	CcSEcCtD
Azithromycin—Dizziness—Prednisolone—psoriasis	7.11e-05	0.000243	CcSEcCtD
Azithromycin—Asthenia—Triamcinolone—psoriasis	7.09e-05	0.000242	CcSEcCtD
Azithromycin—Body temperature increased—Dexamethasone—psoriasis	7.09e-05	0.000242	CcSEcCtD
Azithromycin—Abdominal pain—Betamethasone—psoriasis	7.09e-05	0.000242	CcSEcCtD
Azithromycin—Abdominal pain—Dexamethasone—psoriasis	7.09e-05	0.000242	CcSEcCtD
Azithromycin—Body temperature increased—Betamethasone—psoriasis	7.09e-05	0.000242	CcSEcCtD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	7.08e-05	0.0247	CbGpPWpGaD
Azithromycin—Insomnia—Prednisone—psoriasis	7.06e-05	0.000241	CcSEcCtD
Azithromycin—Nausea—Cyclosporine—psoriasis	7.02e-05	0.00024	CcSEcCtD
Azithromycin—Paraesthesia—Prednisone—psoriasis	7.01e-05	0.00024	CcSEcCtD
Azithromycin—Pruritus—Triamcinolone—psoriasis	6.99e-05	0.000239	CcSEcCtD
Azithromycin—Cough—Methotrexate—psoriasis	6.98e-05	0.000239	CcSEcCtD
Azithromycin—Dizziness—Hydrocortisone—psoriasis	6.94e-05	0.000237	CcSEcCtD
Azithromycin—Convulsion—Methotrexate—psoriasis	6.93e-05	0.000237	CcSEcCtD
Azithromycin—Dyspepsia—Prednisone—psoriasis	6.88e-05	0.000235	CcSEcCtD
Azithromycin—Nausea—Mycophenolate mofetil—psoriasis	6.84e-05	0.000234	CcSEcCtD
Azithromycin—Arthralgia—Methotrexate—psoriasis	6.81e-05	0.000233	CcSEcCtD
Azithromycin—Myalgia—Methotrexate—psoriasis	6.81e-05	0.000233	CcSEcCtD
Azithromycin—Chest pain—Methotrexate—psoriasis	6.81e-05	0.000233	CcSEcCtD
Azithromycin—Decreased appetite—Prednisone—psoriasis	6.79e-05	0.000232	CcSEcCtD
Azithromycin—Rash—Prednisolone—psoriasis	6.78e-05	0.000232	CcSEcCtD
Azithromycin—Dermatitis—Prednisolone—psoriasis	6.77e-05	0.000231	CcSEcCtD
Azithromycin—Fatigue—Prednisone—psoriasis	6.73e-05	0.00023	CcSEcCtD
Azithromycin—Headache—Prednisolone—psoriasis	6.73e-05	0.00023	CcSEcCtD
Azithromycin—Discomfort—Methotrexate—psoriasis	6.73e-05	0.00023	CcSEcCtD
Azithromycin—Constipation—Prednisone—psoriasis	6.68e-05	0.000228	CcSEcCtD
Azithromycin—Vomiting—Hydrocortisone—psoriasis	6.67e-05	0.000228	CcSEcCtD
Azithromycin—Rash—Hydrocortisone—psoriasis	6.62e-05	0.000226	CcSEcCtD
Azithromycin—Dermatitis—Hydrocortisone—psoriasis	6.61e-05	0.000226	CcSEcCtD
Azithromycin—Headache—Hydrocortisone—psoriasis	6.58e-05	0.000225	CcSEcCtD
Azithromycin—Dizziness—Triamcinolone—psoriasis	6.54e-05	0.000223	CcSEcCtD
Azithromycin—Anaphylactic shock—Methotrexate—psoriasis	6.53e-05	0.000223	CcSEcCtD
Azithromycin—Infection—Methotrexate—psoriasis	6.48e-05	0.000222	CcSEcCtD
Azithromycin—Feeling abnormal—Prednisone—psoriasis	6.44e-05	0.00022	CcSEcCtD
Azithromycin—Asthenia—Betamethasone—psoriasis	6.43e-05	0.00022	CcSEcCtD
Azithromycin—Asthenia—Dexamethasone—psoriasis	6.43e-05	0.00022	CcSEcCtD
Azithromycin—Thrombocytopenia—Methotrexate—psoriasis	6.39e-05	0.000218	CcSEcCtD
Azithromycin—Gastrointestinal pain—Prednisone—psoriasis	6.39e-05	0.000218	CcSEcCtD
Azithromycin—Nausea—Prednisolone—psoriasis	6.38e-05	0.000218	CcSEcCtD
Azithromycin—Pruritus—Dexamethasone—psoriasis	6.35e-05	0.000217	CcSEcCtD
Azithromycin—Pruritus—Betamethasone—psoriasis	6.35e-05	0.000217	CcSEcCtD
Azithromycin—Hyperhidrosis—Methotrexate—psoriasis	6.31e-05	0.000216	CcSEcCtD
Azithromycin—Vomiting—Triamcinolone—psoriasis	6.28e-05	0.000215	CcSEcCtD
Azithromycin—Nausea—Hydrocortisone—psoriasis	6.24e-05	0.000213	CcSEcCtD
Azithromycin—Rash—Triamcinolone—psoriasis	6.23e-05	0.000213	CcSEcCtD
Azithromycin—Dermatitis—Triamcinolone—psoriasis	6.23e-05	0.000213	CcSEcCtD
Azithromycin—Anorexia—Methotrexate—psoriasis	6.22e-05	0.000213	CcSEcCtD
Azithromycin—Urticaria—Prednisone—psoriasis	6.2e-05	0.000212	CcSEcCtD
Azithromycin—Headache—Triamcinolone—psoriasis	6.19e-05	0.000212	CcSEcCtD
Azithromycin—Body temperature increased—Prednisone—psoriasis	6.17e-05	0.000211	CcSEcCtD
Azithromycin—Abdominal pain—Prednisone—psoriasis	6.17e-05	0.000211	CcSEcCtD
Azithromycin—Diarrhoea—Betamethasone—psoriasis	6.14e-05	0.00021	CcSEcCtD
Azithromycin—Diarrhoea—Dexamethasone—psoriasis	6.14e-05	0.00021	CcSEcCtD
Azithromycin—Hypotension—Methotrexate—psoriasis	6.1e-05	0.000208	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Methotrexate—psoriasis	5.95e-05	0.000203	CcSEcCtD
Azithromycin—Dizziness—Dexamethasone—psoriasis	5.93e-05	0.000203	CcSEcCtD
Azithromycin—Dizziness—Betamethasone—psoriasis	5.93e-05	0.000203	CcSEcCtD
Azithromycin—Insomnia—Methotrexate—psoriasis	5.9e-05	0.000202	CcSEcCtD
Azithromycin—Nausea—Triamcinolone—psoriasis	5.87e-05	0.000201	CcSEcCtD
Azithromycin—Paraesthesia—Methotrexate—psoriasis	5.86e-05	0.0002	CcSEcCtD
Azithromycin—Dyspnoea—Methotrexate—psoriasis	5.82e-05	0.000199	CcSEcCtD
Azithromycin—Somnolence—Methotrexate—psoriasis	5.8e-05	0.000198	CcSEcCtD
Azithromycin—Hypersensitivity—Prednisone—psoriasis	5.75e-05	0.000197	CcSEcCtD
Azithromycin—Dyspepsia—Methotrexate—psoriasis	5.75e-05	0.000196	CcSEcCtD
Azithromycin—Vomiting—Dexamethasone—psoriasis	5.7e-05	0.000195	CcSEcCtD
Azithromycin—Vomiting—Betamethasone—psoriasis	5.7e-05	0.000195	CcSEcCtD
Azithromycin—Decreased appetite—Methotrexate—psoriasis	5.67e-05	0.000194	CcSEcCtD
Azithromycin—Rash—Betamethasone—psoriasis	5.65e-05	0.000193	CcSEcCtD
Azithromycin—Rash—Dexamethasone—psoriasis	5.65e-05	0.000193	CcSEcCtD
Azithromycin—Dermatitis—Dexamethasone—psoriasis	5.65e-05	0.000193	CcSEcCtD
Azithromycin—Dermatitis—Betamethasone—psoriasis	5.65e-05	0.000193	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Methotrexate—psoriasis	5.64e-05	0.000193	CcSEcCtD
Azithromycin—Fatigue—Methotrexate—psoriasis	5.63e-05	0.000192	CcSEcCtD
Azithromycin—Headache—Dexamethasone—psoriasis	5.62e-05	0.000192	CcSEcCtD
Azithromycin—Headache—Betamethasone—psoriasis	5.62e-05	0.000192	CcSEcCtD
Azithromycin—Asthenia—Prednisone—psoriasis	5.6e-05	0.000192	CcSEcCtD
Azithromycin—Pain—Methotrexate—psoriasis	5.58e-05	0.000191	CcSEcCtD
Azithromycin—Pruritus—Prednisone—psoriasis	5.53e-05	0.000189	CcSEcCtD
Azithromycin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	5.38e-05	0.0188	CbGpPWpGaD
Azithromycin—Feeling abnormal—Methotrexate—psoriasis	5.38e-05	0.000184	CcSEcCtD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.37e-05	0.0187	CbGpPWpGaD
Azithromycin—Diarrhoea—Prednisone—psoriasis	5.34e-05	0.000183	CcSEcCtD
Azithromycin—Gastrointestinal pain—Methotrexate—psoriasis	5.34e-05	0.000182	CcSEcCtD
Azithromycin—Nausea—Dexamethasone—psoriasis	5.33e-05	0.000182	CcSEcCtD
Azithromycin—Nausea—Betamethasone—psoriasis	5.33e-05	0.000182	CcSEcCtD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.3e-05	0.0185	CbGpPWpGaD
Azithromycin—Urticaria—Methotrexate—psoriasis	5.19e-05	0.000177	CcSEcCtD
Azithromycin—Dizziness—Prednisone—psoriasis	5.16e-05	0.000177	CcSEcCtD
Azithromycin—Abdominal pain—Methotrexate—psoriasis	5.16e-05	0.000176	CcSEcCtD
Azithromycin—Body temperature increased—Methotrexate—psoriasis	5.16e-05	0.000176	CcSEcCtD
Azithromycin—Vomiting—Prednisone—psoriasis	4.97e-05	0.00017	CcSEcCtD
Azithromycin—Rash—Prednisone—psoriasis	4.92e-05	0.000168	CcSEcCtD
Azithromycin—Dermatitis—Prednisone—psoriasis	4.92e-05	0.000168	CcSEcCtD
Azithromycin—Headache—Prednisone—psoriasis	4.89e-05	0.000167	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—CYP2S1—psoriasis	4.87e-05	0.017	CbGpPWpGaD
Azithromycin—Hypersensitivity—Methotrexate—psoriasis	4.81e-05	0.000164	CcSEcCtD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	4.69e-05	0.0164	CbGpPWpGaD
Azithromycin—Asthenia—Methotrexate—psoriasis	4.68e-05	0.00016	CcSEcCtD
Azithromycin—Nausea—Prednisone—psoriasis	4.64e-05	0.000159	CcSEcCtD
Azithromycin—Pruritus—Methotrexate—psoriasis	4.62e-05	0.000158	CcSEcCtD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	4.52e-05	0.0158	CbGpPWpGaD
Azithromycin—Diarrhoea—Methotrexate—psoriasis	4.47e-05	0.000153	CcSEcCtD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.35e-05	0.0152	CbGpPWpGaD
Azithromycin—Dizziness—Methotrexate—psoriasis	4.32e-05	0.000148	CcSEcCtD
Azithromycin—Vomiting—Methotrexate—psoriasis	4.15e-05	0.000142	CcSEcCtD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.15e-05	0.0145	CbGpPWpGaD
Azithromycin—Rash—Methotrexate—psoriasis	4.12e-05	0.000141	CcSEcCtD
Azithromycin—Dermatitis—Methotrexate—psoriasis	4.11e-05	0.000141	CcSEcCtD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	4.1e-05	0.0143	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.09e-05	0.0143	CbGpPWpGaD
Azithromycin—Headache—Methotrexate—psoriasis	4.09e-05	0.00014	CcSEcCtD
Azithromycin—Nausea—Methotrexate—psoriasis	3.88e-05	0.000133	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.36e-05	0.0117	CbGpPWpGaD
Azithromycin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	3.32e-05	0.0116	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	3.19e-05	0.0111	CbGpPWpGaD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.09e-05	0.0108	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—TGFA—psoriasis	2.71e-05	0.00945	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	2.63e-05	0.00918	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	2.58e-05	0.00899	CbGpPWpGaD
Azithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.47e-05	0.0086	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—HLA-C—psoriasis	2.46e-05	0.00859	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL13—psoriasis	2.45e-05	0.00854	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	2.31e-05	0.00807	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	2.28e-05	0.00795	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	2.28e-05	0.00794	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL17A—psoriasis	2.25e-05	0.00786	CbGpPWpGaD
Azithromycin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	2.24e-05	0.00782	CbGpPWpGaD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.15e-05	0.00751	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL12B—psoriasis	2.09e-05	0.0073	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—HLA-E—psoriasis	2.04e-05	0.00713	CbGpPWpGaD
Azithromycin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	2e-05	0.00696	CbGpPWpGaD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.9e-05	0.00664	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.79e-05	0.00622	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.76e-05	0.00614	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	1.74e-05	0.00605	CbGpPWpGaD
Azithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.72e-05	0.006	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.69e-05	0.0059	CbGpPWpGaD
Azithromycin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.54e-05	0.00537	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL10—psoriasis	1.53e-05	0.00534	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL4—psoriasis	1.49e-05	0.0052	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—HLA-B—psoriasis	1.46e-05	0.00508	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	1.46e-05	0.00507	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	1.36e-05	0.00473	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—HLA-A—psoriasis	1.35e-05	0.00471	CbGpPWpGaD
Azithromycin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	1.33e-05	0.00465	CbGpPWpGaD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.33e-05	0.00463	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	1.23e-05	0.0043	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.11e-05	0.00386	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NDUFA5—psoriasis	9.79e-06	0.00341	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	9.58e-06	0.00334	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.22e-06	0.00322	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IFNG—psoriasis	9.01e-06	0.00314	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	8.99e-06	0.00313	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—CXCL8—psoriasis	8.37e-06	0.00292	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	8.37e-06	0.00292	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP2S1—psoriasis	8.33e-06	0.0029	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	7.85e-06	0.00274	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.17e-06	0.0025	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.17e-06	0.0025	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.9e-06	0.00241	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—VEGFA—psoriasis	6.8e-06	0.00237	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—TNF—psoriasis	5.83e-06	0.00203	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NDUFA5—psoriasis	5.83e-06	0.00203	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.79e-06	0.00202	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	5.42e-06	0.00189	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	5.17e-06	0.0018	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP2S1—psoriasis	4.95e-06	0.00173	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NDUFA5—psoriasis	4.65e-06	0.00162	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.34e-06	0.00151	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CARM1—psoriasis	4.07e-06	0.00142	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP2S1—psoriasis	3.96e-06	0.00138	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.84e-06	0.00134	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.7e-06	0.00129	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NDUFA5—psoriasis	3.59e-06	0.00125	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.36e-06	0.00117	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP2S1—psoriasis	3.05e-06	0.00106	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.88e-06	0.001	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.54e-06	0.000884	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CAT—psoriasis	2.5e-06	0.000872	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CARM1—psoriasis	2.42e-06	0.000844	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.07e-06	0.000723	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—APOE—psoriasis	1.94e-06	0.000678	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CARM1—psoriasis	1.93e-06	0.000674	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.81e-06	0.00063	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PPARG—psoriasis	1.69e-06	0.00059	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CARM1—psoriasis	1.49e-06	0.00052	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CAT—psoriasis	1.49e-06	0.000519	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CAT—psoriasis	1.19e-06	0.000414	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—APOE—psoriasis	1.16e-06	0.000403	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PPARG—psoriasis	1.01e-06	0.000351	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—APOE—psoriasis	9.23e-07	0.000322	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CAT—psoriasis	9.17e-07	0.00032	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PPARG—psoriasis	8.04e-07	0.00028	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—APOE—psoriasis	7.12e-07	0.000248	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PPARG—psoriasis	6.21e-07	0.000216	CbGpPWpGaD
